Two pediatric cases with hematuria, normal renal function and positive antineutrophil cytoplasmic antibodies
1
조회
0
다운로드
0
인용
0
참고문헌
키워드
초록
Antineutrophil cytoplasmic antibody (ANCA)-associated glomerulonephritis requires prompt diagnosis and treatment, since renal function at the time of diagnosis is significantly associated with renal outcomes. Here, we report two pediatric patients with ANCA-positive glomerulonephritis initially presenting with hematuria, mild proteinuria, and normal renal function. The first patient with a high myeloperoxidase-ANCA titer (>134 IU/mL) was diagnosed with rapidly progressive glomerulonephritis based on renal biopsy and treated with immunosuppressive therapy after 10 months of follow-up. The second patient with a low myeloperoxidase-ANCA titer (11 IU/mL) maintained normal kidney function without medication. Two cases showed different clinical course according to ANCA titer.
Abstract
Antineutrophil cytoplasmic antibody (ANCA)-associated glomerulonephritis requires prompt diagnosis and treatment, since renal function at the time of diagnosis is significantly associated with renal outcomes. Here, we report two pediatric patients with ANCA-positive glomerulonephritis initially presenting with hematuria, mild proteinuria, and normal renal function. The first patient with a high myeloperoxidase-ANCA titer (>134 IU/mL) was diagnosed with rapidly progressive glomerulonephritis based on renal biopsy and treated with immunosuppressive therapy after 10 months of follow-up. The second patient with a low myeloperoxidase-ANCA titer (11 IU/mL) maintained normal kidney function without medication. Two cases showed different clinical course according to ANCA titer.
참고문헌 (15)
- Jennette JC, "Rapidly progressive crescentic glomerulonephritis", Kidney Int, 63, pp.1164~1177 (2003)
- Hauer HA, "Determinants of outcome in ANCA-associated glomerulonephritis : a prospective clinico-histopathological analysis of 96 patients", Kidney Int, 62, pp.1732~1742 (2002)
- Vergunst CE, "An index for renal outcome in ANCA-associated glomerulonephritis", Am J Kidney Dis, 41, pp.532~538 (2003)
- Booth AD, "Outcome of ANCA-associated renal vasculitis : a 5-year retrospective study", Am J Kidney Dis, 41, pp.776~784 (2003)
- Fussner LA, "Factors determining the clinical utility of serial measurements of antineutrophil cytoplasmic antibodies targeting proteinase 3", Arthritis Rheumatol, 68, pp.1700~1710 (2016)
- Cohen RA, "Microscopic hematuria", N Engl J Med, 348, pp.2330~2338 (2003)
- Guchelaar NAD, "The value of anti-neutrophil cytoplasmic antibodies (ANCA) testing for the diagnosis of ANCA-associated vasculitis, a systematic review and meta-analysis", Autoimmun Rev, 20, pp.102716~ (2021)
- Gaffo AL, "Diagnostic approach to ANCA-associated vasculitides", Rheum Dis Clin North Am, 36, pp.491~506 (2010)
- Hagen EC, "Diagnostic value of standardized assays for anti-neutrophil cytoplasmic antibodies in idiopathic systemic vasculitis", Kidney Int, 53, pp.743~753 (1998)
- Houben E, "Diagnosing ANCA-associated vasculitis in ANCA positive patients:a retrospective analysis on the role of clinical symptoms and the ANCA titre", Medicine(Baltimore), 95, pp.e5096~ (2016)
- Kerr GS, "Limited prognostic value of changes in antineutrophil cytoplasmic antibody titer in patients with Wegener's granulomatosis", Arthritis Rheum, 36, pp.365~371 (1993)
- Baskin E, "Ceruloplasmin levels in antineutrophil cytoplasmic antibody-positive patients", Pediatr Nephrol, 17, pp.917~919 (2002)
- Jennette JC, "ANCA glomerulonephritis and vasculitis", Clin J Am Soc Nephrol, 12, pp.1680~1691 (2017)
- Jayne DR, "Randomized trial of plasma exchange or high-dosage methylprednisolone as adjunctive therapy for severe renal vasculitis", J Am Soc Nephrol, 18, pp.2180~2188 (2007)
- Smith RM, "Progress in treatment of ANCA-associated vasculitis", Arthritis Res Ther, 14, pp.210~ (2012)